
Sequences of primer sets used_
| Gene targeted | Sequence | Size of amplified product (bp) | Ref |
|---|---|---|---|
| glmM | F: 5′-AAGCTTTTAGGGGTGTTAGGGGTTT-3′ | 294 | Santos et al. 2012 |
| cagA | F: 5′-GATAACAGGCAAGCTTTTGAGG-3′ | 349 | Amin et al. 2019 |
| sodB | F: 5′-GCCCTGTGGCGTTTGATTTCC-3′ | 425 | Ryberg et al. 2008 |
| hsp60 | F: 5′-GCTCCAAGCATCACCAAAGACG-3′ | 603 | Ryberg et al. 2008 |
| vacA | F: 5′-CAATCGTGTGGGTTCTGGAGC-3′ | 678 | Ryberg et al. 2008 |
| vacAs1/s2 | F: 5′-ATGGAAATACAACAAACACAC-3′ | 259 | Harrison et al. 2017 |
| vacAm1 | F: 5′-GGTCAAAATGCGGTCATGG-3′ | 290 | Harrison et al. 2017 |
| vacAm2 | F: 5′-CATAACTAGCGCCTTGCAC-3′ | 352 | Harrison et al. 2017 |
| TLR9-1486T/C, rs187084 | 5′-TTCATTCATTCAGCCTTCACTCA-3′ | 490 | Roszak et al. 2012 |
Distribution of H_ pylori among gastric tissue samples in studied gastric cancer patients_
| Number | % | p-value | |
|---|---|---|---|
| Positive | 106 | 80.3 | 0.000* |
| Negative | 26 | 19.7 | |
| Total | 132 | 100% |
Distribution of genotypes of TLR9 -1486T/C, rs187084 polymorphism in studied groups_
| Genotype frequency | Healthy study participants N = 106 | Gastric cancer patients N = 106 | OR | 95% CI | X2 | p-value | ||
|---|---|---|---|---|---|---|---|---|
| N | % | N | % | |||||
| TT | 40 | 37.7 | 22 | 20.8 | 1.18 | 0.45–3.1 | 0.12 | 0.73 |
| TC | 42 | 39.6 | 28 | 26.4 | 1.2 | 0.49–2.88 | 0.16 | 0.68 |
| CC | 24 | 22.6 | 56 | 52.8 | 2.68 | 1.0–7.14 | 4.03 | 0.045* |
Demographic and histopathological data of the subjects included in the study_
| Variable | Gastric cancer patients | Healthy study participants | p-value |
|---|---|---|---|
| Age | |||
| Years (mean ± SD) | 56.55 ± 8.63 | 53.27 ± 8.55 | 0.93 |
| Sex | |||
| Male | 63 (59.4) | 59 (55.7%) | 0.76 |
| Female | 43 (40.6%) | 47 (44.3%) | |
| Differentiation of the tumor | |||
| Well differentiated tumor | 16 (15.1%) | NA | – |
| Moderately differentiated tumor | 35 (33.0%) | ||
| Poorly differentiated tumor | 55 (51.9%) | ||
Distribution of virulence genes in H_ pylori strains isolated from gastric cancer patients_
| Virulence gene | N = 106 | % | p-value |
|---|---|---|---|
| cagA | |||
| Positive | 96 | 90.6 | 0.000* |
| Negative | 10 | 9.4 | |
| sodB | |||
| Positive | 75 | 70.8 | 0.000* |
| Negative | 31 | 29.2 | |
| hsp60 | |||
| Positive | 88 | 83.0 | 0.000* |
| Negative | 18 | 17.0 | |
| vacA | |||
| Positive | 101 | 95.3 | 0.000* |
| Negative | 5 | 4.7 | |
| vacAs1/s2 | |||
| Positive | 101 | 95.3 | 0.000* |
| Negative | 5 | 4.7 | |
| vacAm1 | |||
| Positive | 56 | 52.8 | 0.56 |
| Negative | 50 | 47.2 | |
| vacAm2 | |||
| Positive | 45 | 42.5 | 0.12 |
| Negative | 61 | 57.5 | |
The relation between virulence genes of H_ pylori and TLR9 -1486T/C, rs187084 genotypes in gastric cancer patients_
| TLR9-1486T/C, rs187084 genotype | CC N = 56 | TT + TC N = 50 | p-value | ||
|---|---|---|---|---|---|
| Virulence gene | N | % | N | % | |
| cagA | 55 | 98.2 | 41 | 82.0 | 0.075 |
| sodB | 53 | 94.6 | 22 | 44.0 | 0.021* |
| hsp60 | 53 | 94.6 | 35 | 70.0 | 0.049* |
| vacA | 54 | 96.4 | 47 | 94.0 | 0.88 |
| vacAs1/s2 | 54 | 96.4 | 47 | 94.0 | 0.88 |
| vacAm1 | 35 | 62.5 | 21 | 42.0 | 0.048* |
| vacAm2 | 19 | 33.9 | 26 | 52.0 | 0.81 |